Caribou Biosciences Inc (CRBU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,293 | 31,970 | 37,866 | 49,400 | 51,162 |
| Marketable Securities | 193,244 | 196,208 | 223,783 | 244,588 | 277,665 |
| Receivables | 2,093 | 1,867 | 1,944 | 2,642 | 2,434 |
| Other current assets | 1,158 | 798 | 972 | 971 | 1,425 |
| TOTAL | $219,377 | $237,426 | $270,882 | $304,514 | $338,841 |
| Non-Current Assets | |||||
| PPE Net | 19,281 | 19,565 | 19,876 | 19,167 | 18,270 |
| Investments And Advances | 49,125 | 62,109 | 59,410 | 59,691 | 51,330 |
| Other Non-Current Assets | 25,530 | 25,234 | 22,770 | 23,453 | 23,768 |
| TOTAL | $93,936 | $106,908 | $102,056 | $102,311 | $93,368 |
| Total Assets | $313,313 | $344,334 | $372,938 | $406,825 | $432,209 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,476 | 2,704 | 3,227 | 5,940 | 3,120 |
| Accrued Expenses | 23,620 | 25,448 | 23,626 | 18,990 | 21,135 |
| TOTAL | $30,651 | $32,159 | $30,944 | $29,021 | $28,302 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,129 | 2,829 | 2,829 | 2,827 | 2,847 |
| Other Non-Current Liabilities | 25,846 | 26,468 | 26,369 | 28,531 | 28,847 |
| TOTAL | $29,711 | $30,972 | $31,530 | $34,515 | $35,506 |
| Total Liabilities | $60,362 | $63,131 | $62,474 | $63,536 | $63,808 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 93,005 | 90,553 | 90,363 | 90,318 | 90,315 |
| Common Shares | 9 | 9 | 9 | 9 | 8 |
| Retained earnings | -448,390 | -412,900 | -378,216 | -340,519 | -299,285 |
| Other shareholders' equity | 255 | 789 | -319 | -322 | 30 |
| TOTAL | $252,951 | $281,203 | $310,464 | $343,289 | $368,401 |
| Total Liabilities And Equity | $313,313 | $344,334 | $372,938 | $406,825 | $432,209 |